TD Cowen downgraded Illumina Inc (NASDAQ:ILMN) to "Hold" following the company's fourth-quarter earnings, citing weaker-than-expected next-generation sequencing (NGS) consumable growth, increasing ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

CEO Jacob Thaysen highlighted the transformative progress Illumina made in 2024, emphasizing its strategic roadmap targeting high single-digit revenue growth by 2027. He noted significant advancements ...

Genomics company Illumina (NASDAQ:ILMN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales ...

His research explores the rise of generative AI and accelerated use of AI more broadly to advance drug and scientific discovery. Reuben leads Gartner's coverage of genomics, multiomics, cell and gene ...

Amazon prepares to release Alexa generative AI revamp after delays * Amazon invites press to event in late * Alexa could come ...

Amazon is set to release its long-awaited - and delayed - Alexa generative Artificial Intelligence (AI) voice service, said ...

The AI service will be able to respond to multiple prompts in sequence and, company executives have said, even act as an ...

The company reiterated its full-year 2025 guidance of 3% to 5% organic revenue growth and 300 basis points of adjusted EBITDA margin expansion. Multiomics is expected to grow in the low single digits, ...